Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoaki Sano

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Bioscience, Biotechnology, and Biochemistry|April 26, 2016
Aspergillus oryzae nrtA affects kojic acid productionMotoaki Sano
Circulation Journal : Official Journal of the Japanese Circulation Society|October 24, 2009
Mitochondrial protection and the reversal of left ventricular remodelingMotoaki Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 18, 2018
Advances in geroscience: Cardiovascular diseaseMotoaki Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2016
[Control of coronary blood flow]Motoaki Sano
Therapeutic Advances in Cardiovascular Disease|July 28, 2020
Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activationMotoaki Sano
Journal of Atherosclerosis and Thrombosis|June 30, 2020
A Paradigm Shift in the Treatment of Type 2 Diabetes and Heart FailureMotoaki Sano
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 16, 2011
Revisiting the merits of nifedipineMotoaki Sano
International Journal of Molecular Sciences|March 29, 2023
A Role of Sodium-Glucose Co-Transporter 2 in Cardiorenal Anemia Iron Deficiency SyndromeMotoaki Sano
Journal of Clinical Medicine Research|May 13, 2017
Hemodynamic Effects of Sodium-Glucose Cotransporter 2 InhibitorsMotoaki Sano
Journal of Cardiology|February 9, 2018
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivityMotoaki Sano
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Bioscience, Biotechnology, and Biochemistry|April 26, 2016
Aspergillus oryzae nrtA affects kojic acid productionMotoaki Sano
Circulation Journal : Official Journal of the Japanese Circulation Society|October 24, 2009
Mitochondrial protection and the reversal of left ventricular remodelingMotoaki Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 18, 2018
Advances in geroscience: Cardiovascular diseaseMotoaki Sano
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2016
[Control of coronary blood flow]Motoaki Sano
Therapeutic Advances in Cardiovascular Disease|July 28, 2020
Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activationMotoaki Sano
Journal of Atherosclerosis and Thrombosis|June 30, 2020
A Paradigm Shift in the Treatment of Type 2 Diabetes and Heart FailureMotoaki Sano
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 16, 2011
Revisiting the merits of nifedipineMotoaki Sano
International Journal of Molecular Sciences|March 29, 2023
A Role of Sodium-Glucose Co-Transporter 2 in Cardiorenal Anemia Iron Deficiency SyndromeMotoaki Sano
Journal of Clinical Medicine Research|May 13, 2017
Hemodynamic Effects of Sodium-Glucose Cotransporter 2 InhibitorsMotoaki Sano
Journal of Cardiology|February 9, 2018
A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivityMotoaki Sano
Pageof 30